Pharmaceutical Preparations · DE · CIK 1393434
Develops and commercializes ophthalmic therapies using proprietary hydrogel technology for sustained drug delivery
Comparable business profile · signals at a glance
In the 90 days to Feb 23, 2026: 1 insider bought $461K · 6 sold $1.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Dugel PravinSee Remarks | Sell | 20,056 | $8.28 | $166K |
| Feb 23, 2026 | Heier Jeffrey S.Chief Scientific Officer | Sell | 3,057 | $8.28 | $25K |
| Feb 23, 2026 | Kaiser PeterChief Development Officer | Sell | 2,810 | $8.28 | $23K |
| Feb 23, 2026 | Nayak SanjayChief Strategy Officer | Sell | 1,759 | $8.28 | $15K |
| Feb 20, 2026 | Lindstrom Richard L MdDirector | Buy | 60,229 | $7.66 | $461K |
| Feb 20, 2026 | Waheed NadiaChief Medical Officer | Sell | 3,510 | $7.74 | $27K |
| Feb 12, 2026 | Dugel PravinSee Remarks | Sell | 124,882 | $9.04 | $1.1M |
| Feb 12, 2026 | Notman DonaldChief Operating Officer | Sell | 11,446 | $9.04 | $103K |
| Feb 12, 2026 | Nayak SanjayChief Strategy Officer | Sell | 10,348 | $9.04 | $94K |
| Feb 12, 2026 | Waheed NadiaChief Medical Officer | Sell | 7,863 | $9.04 | $71K |
| Feb 4, 2026 | Notman DonaldChief Operating Officer | Sell | 6,035 | $8.54 | $52K |
| Feb 2, 2026 | Notman DonaldChief Operating Officer | Sell | 5,455 | $9.14 | $50K |
| Nov 24, 2025 | Dugel PravinSee Remarks | Sell | 19,530 | $12.04 | $235K |
| Nov 24, 2025 | Heier Jeffrey S.Chief Scientific Officer | Sell | 3,469 | $12.04 | $42K |
| Nov 24, 2025 | Kaiser PeterChief Development Officer | Sell | 3,007 | $12.02 | $36K |
| Nov 24, 2025 | Nayak SanjayChief Strategy Officer | Sell | 1,878 | $12.04 | $23K |
| Nov 5, 2025 | Saroj NamrataChief Business Officer | Sell | 25,865 | $10.74 | $278K |
| Oct 8, 2025 | Anderman ToddChief Legal Officer | Sell | 11,132 | $12.34 | $137K |
| Oct 2, 2025 | Heier Jeffrey S.Chief Scientific Officer | Sell | 10,502 | $11.04 | $116K |
| Oct 2, 2025 | Kaiser PeterChief Development Officer | Sell | 9,653 | $11.03 | $106K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.